{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:56:04Z","timestamp":1787162164315,"version":"build-2736575974"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T00:00:00Z","timestamp":1704844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Investigator-Initiated Studies Program of Organon"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3,1]]},"abstract":"Abstract<\/jats:title>\n \n STUDY QUESTION<\/jats:title>\n Is there an increase in the total number of metaphase II (MII) oocytes between a conventional ovarian stimulation (OS) and a double uninterrupted stimulation?<\/jats:p>\n <\/jats:sec>\n \n SUMMARY ANSWER<\/jats:title>\n There is no increase in the total number of MII oocytes when comparing one conventional OS to a continuous stimulation with double oocyte aspiration.<\/jats:p>\n <\/jats:sec>\n \n WHAT IS KNOWN ALREADY<\/jats:title>\n Based on the concept of multiple follicular waves, the combination of two stimulations in the same ovarian cycle has gained interest in patients with a low ovarian reserve. This so-called dual stimulation approach is usually characterized by a discontinuation of FSH administration for \u223c5\u2009days and appears to have a favourable impact on the number of retrieved oocytes without affecting the embryo quality or ploidy status. The outcomes of dual uninterrupted OS have not yet been studied.<\/jats:p>\n <\/jats:sec>\n \n STUDY DESIGN, SIZE, DURATION<\/jats:title>\n This was an open-label randomized controlled trial (RCT) with superiority design, performed in a single tertiary centre. Subjects were randomized with a 1:1 allocation into two groups between October 2019 and September 2021. All patients underwent a conventional stimulation with recombinant FSH. When two or more follicles of 17\u2009mm were present, the final inclusion criterion was assessed; randomization occurred only in the presence of \u22649 follicles of \u226511\u2009mm. In Group A, ovulation was triggered with hCG, and oocyte retrieval (OR) was performed 34\u201336\u2009h later, followed by a fresh single or double embryo transfer (SET or DET) on Day 3\/5. In Group B, ovulation was triggered with GnRH agonist, followed by another OS, without discontinuation of the FSH administration. In the presence of one or more follicles of \u226517\u2009mm, the second stimulation was completed with hCG. A freeze-all strategy (Day 3\/5) was applied for both retrievals, followed by transfer of one or two embryos in an artificially prepared frozen-thawed cycle. In the absence of one or more follicles of \u226517\u2009mm after 13 additional days of stimulation, the second cycle was cancelled. All ORs were executed by a senior fertility specialist who was blinded for the first treatment, and all follicles &gt;10\u2009mm were aspirated, according to routine clinical practice. The primary outcome was the total number of MII oocytes. Patients were followed up until all embryos were transferred, or until live birth was achieved. Other secondary outcomes included the number of cumulus\u2013oocyte complexes (COCs), the number of good quality embryos (Day 3\/5), the ongoing pregnancy rate, and gonadotropin consumption.<\/jats:p>\n <\/jats:sec>\n \n PARTICIPANTS\/MATERIALS, SETTING, METHODS<\/jats:title>\n Patients between 25 and 40\u2009years old, with an anti-M\u00fcllerian hormone level of \u22641.5\u2009ng\/ml, antral follicle count of \u22646, or \u22645 oocytes after a previous stimulation, were included. At the start, 70 patients were eligible for participation in the trial, of whom 48 patients fulfilled the final inclusion criterium and were randomized. After drop-out of two patients, 23 patients were randomized to a single round of OS (Group A), and 23 patients were randomized to two uninterrupted rounds of OS (Group B).<\/jats:p>\n <\/jats:sec>\n \n MAIN RESULTS AND THE ROLE OF CHANCE<\/jats:title>\n Baseline characteristics were similar between both groups. The cumulative number of COCs and MII oocytes after completion of the second OR was similar in Group A and Group B [5.3\u2009\u00b1\u20092.7 versus 5.3\u2009\u00b1\u20093.0 (P\u2009=\u20090.95); 4.1\u2009\u00b1\u20092.4 versus 4.3\u2009\u00b1\u20092.7 (P\u2009=\u20090.77)]. Likewise, a comparable number of excellent and good quality embryos was available on Day 3 (3.0\u2009\u00b1\u20092.0 versus 2.7\u2009\u00b1\u20092.0; P\u2009=\u20090.63). In Group B, the cancellation rate due to insufficient response to the second round of stimulation was 39.1% (9\/23). When focusing on the first stimulation in both groups, there were no significant differences regarding basal FSH, gonadotropin consumption, and the number of preovulatory follicles. After the first OR, the mean number of COC and MII oocytes was significantly higher in Group A (who had hCG triggering), compared to Group B (who had GnRH agonist triggering) [5.3\u2009\u00b1\u20092.7 versus 3.3\u2009\u00b1\u20092.2; difference 95% CI (0.54 to 3.45), P\u2009=\u20090.004 and 4.1\u2009\u00b1\u20092.4 versus 3.0\u2009\u00b1\u20092.2; difference 95% CI (\u22120.15 to 2.6), P\u2009=\u20090.05, respectively]. Likewise, the number of excellent and good quality embryos on Day 3 was significantly higher (3.0\u2009\u00b1\u20092.0 versus 1.9\u2009\u00b1\u20091.7; P\u2009=\u20090.02) in Group A.<\/jats:p>\n <\/jats:sec>\n \n LIMITATIONS, REASONS FOR CAUTION<\/jats:title>\n This study was powered to demonstrate superiority for the number of MII oocytes after dual stimulation. Investigating the impact of dual stimulation on pregnancy rates would have required a larger sample size. Furthermore, the heterogeneity in embryo vitrification and transfer policies precluded a correct comparison of embryologic outcomes between both groups.<\/jats:p>\n <\/jats:sec>\n \n WIDER IMPLICATIONS OF THE FINDINGS<\/jats:title>\n This is the first RCT investigating the role of continuous stimulation with double aspiration in low responders. Our results show no statistically significant differences in the cumulative number of MII oocytes between one conventional stimulation with fresh ET and two consecutive stimulations with a freeze-only approach. Furthermore, the observed suboptimal oocyte yield after agonist ovulation triggering in low responders in the dual uninterrupted OS group is a reason for concern and further scrutiny, given that previous RCTs have shown similar outcomes in normal and high responders after hCG and GnRH agonist triggers.<\/jats:p>\n <\/jats:sec>\n \n STUDY FUNDING\/COMPETING INTEREST(S)<\/jats:title>\n This work was supported in part by a research grant from Organon. H.T. received honoraria for lectures and presentations from Abbott, Cooper Surgical, Gedeon-Richter, Cook, Goodlife, and Ferring. L.B. received fees for lectures from Merck & Organon and support for attending ESHRE 2023. M.D.V. reports fees for lectures from Ferring, Merck, Organon, IBSA, Gedeon Richter, and Cooper Surgical and support for attending ASRM 2023. S.M. received honoraria for lectures and presentations from Abbott, Cooper Surgical, Gedeon-Richter, IBSA, and Merck. C.B. was on the Advisory board and received consulting fees from Theramex and received honoraria for lectures and presentations from Abbott, Ferring, Gedeon-Richter, IBSA, and Merck.<\/jats:p>\n <\/jats:sec>\n \n TRIAL REGISTRATION NUMBER<\/jats:title>\n NCT03846544<\/jats:p>\n <\/jats:sec>\n \n TRIAL REGISTRATION DATE<\/jats:title>\n 19 February 2019<\/jats:p>\n <\/jats:sec>\n \n DATE OF FIRST PATIENT\u2019S ENROLMENT<\/jats:title>\n 28 October 2019<\/jats:p>\n <\/jats:sec>","DOI":"10.1093\/humrep\/dead276","type":"journal-article","created":{"date-parts":[[2023,12,23]],"date-time":"2023-12-23T02:25:16Z","timestamp":1703298316000},"page":"538-547","source":"Crossref","is-referenced-by-count":16,"title":["Does dual oocyte retrieval with continuous FSH administration increase the number of mature oocytes in low responders? An open-label randomized controlled trial"],"prefix":"10.1093","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3175-2996","authenticated-orcid":false,"given":"L","family":"Boudry","sequence":"first","affiliation":[{"name":"Brussels IVF, Centre for Reproductive Medicine, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel , Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5262-4948","authenticated-orcid":false,"given":"I","family":"Mateizel","sequence":"additional","affiliation":[{"name":"Brussels IVF, Centre for Reproductive Medicine, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel , Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3285-8939","authenticated-orcid":false,"given":"K","family":"Wouters","sequence":"additional","affiliation":[{"name":"Brussels IVF, Centre for Reproductive Medicine, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel , Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0281-9143","authenticated-orcid":false,"given":"E","family":"Papaleo","sequence":"additional","affiliation":[{"name":"Obstetrics and Gynaecology Department, IRCCS San Raffaele Scientific Institute , Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7012-0436","authenticated-orcid":false,"given":"S","family":"Mackens","sequence":"additional","affiliation":[{"name":"Brussels IVF, Centre for Reproductive Medicine, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel , Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5019-5924","authenticated-orcid":false,"given":"M","family":"De Vos","sequence":"additional","affiliation":[{"name":"Brussels IVF, Centre for Reproductive Medicine, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel , Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2494-9830","authenticated-orcid":false,"given":"A","family":"Racca","sequence":"additional","affiliation":[{"name":"Department of Gynaecology and Reproductive Medicine, Instituto Bernabeu Venezia , Venezia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Adriaenssens","sequence":"additional","affiliation":[{"name":"Laboratory of Follicle Biology, Vrije Universiteit Brussel , Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9863-9309","authenticated-orcid":false,"given":"H","family":"Tournaye","sequence":"additional","affiliation":[{"name":"Brussels IVF, Centre for Reproductive Medicine, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel , Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7129-5158","authenticated-orcid":false,"given":"C","family":"Blockeel","sequence":"additional","affiliation":[{"name":"Brussels IVF, Centre for Reproductive Medicine, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel , Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,1,10]]},"reference":[{"key":"2024030111172049400_dead276-B1","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/j.fertnstert.2006.05.049","article-title":"Triggering ovulation with gonadotropin-releasing hormone agonists does not compromise embryo implantation rates","volume":"86","author":"Acevedo","year":"2006","journal-title":"Fertil Steril"},{"key":"2024030111172049400_dead276-B2","doi-asserted-by":"crossref","first-page":"28","DOI":"10.5935\/1518-0557.20210039","article-title":"Dual trigger with gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves oocyte yield in normal responders on GnRH-antagonist cycles","volume":"26","author":"Albeitawi","year":"2022","journal-title":"JBRA Assist Reprod"},{"key":"2024030111172049400_dead276-B3","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.rbmo.2019.01.007","article-title":"Dual stimulation using corifollitropin alfa in 54 Bologna criteria poor ovarian responders\u2014a case series","volume":"38","author":"Alsbjerg","year":"2019","journal-title":"Reprod Biomed Online"},{"key":"2024030111172049400_dead276-B4","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0015-0282(03)00544-2","article-title":"A new model for ovarian follicular development during the human menstrual cycle","volume":"80","author":"Baerwald","year":"2003","journal-title":"Fertil Steril"},{"key":"2024030111172049400_dead276-B151","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s10815-010-9429-0","article-title":"Ovarian stimulation during the luteal phase for fertility preservation of cancer patients: case reports and review of the literature","volume":"27","author":"Bedoschi","year":"2010","journal-title":"J Assist Reprod Gen"},{"key":"2024030111172049400_dead276-B5","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1080\/09513590.2020.1822804","article-title":"DuoStim cycles potentially boost reproductive outcomes in poor prognosis patients","volume":"37","author":"Cecchino","year":"2021","journal-title":"Gynecol Endocrinol"},{"key":"2024030111172049400_dead276-B6","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.rbmo.2022.11.012","article-title":"A randomized, non-inferiority trial on the DuoStim strategy in PGT-A cycles","volume":"46","author":"Cerrillo","year":"2022","journal-title":"Reprod Biomed Online"},{"key":"2024030111172049400_dead276-B7","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.fertnstert.2015.02.020","article-title":"Comparison of live-birth defects after luteal-phase ovarian stimulation vs. conventional ovarian stimulation for in vitro fertilization and vitrified embryo transfer cycles","volume":"103","author":"Chen","year":"2015","journal-title":"Fertil Steril"},{"key":"2024030111172049400_dead276-B8","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1093\/humrep\/dey217","article-title":"Luteal phase anovulatory follicles result in the production of competent oocytes: intra-patient paired case-control study comparing follicular versus luteal phase stimulations in the same ovarian cycle","volume":"33","author":"Cimadomo","year":"2018","journal-title":"Hum Reprod"},{"key":"2024030111172049400_dead276-B9","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3389\/fendo.2019.00387","article-title":"Management of women with an unexpected low ovarian response to gonadotropin","volume":"10","author":"Conforti","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2024030111172049400_dead276-B10","doi-asserted-by":"crossref","first-page":"2633494120941480","DOI":"10.1177\/2633494120941480","article-title":"Update on the management of poor ovarian response in IVF: the shift from Bologna criteria to the Poseidon concept","volume":"14","author":"Drakopoulos","year":"2020","journal-title":"Ther Adv Reprod Health"},{"key":"2024030111172049400_dead276-B11","first-page":"370","article-title":"Conventional ovarian stimulation and single embryo transfer for IVF\/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?","volume":"31","author":"Drakopoulos","year":"2016","journal-title":"Hum Reprod"},{"key":"2024030111172049400_dead276-B12","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1093\/humrep\/dex296","article-title":"Corifollitropin alfa followed by highly purified HMG versus recombinant FSH in young poor ovarian responders: a multicentre randomized controlled clinical trial","volume":"32","author":"Drakopoulos","year":"2017","journal-title":"Hum Reprod"},{"key":"2024030111172049400_dead276-B13","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.fertnstert.2013.05.028","article-title":"Early luteal phase endocrine profile is affected by the mode of triggering final oocyte maturation and the luteal phase support used in recombinant follicle-stimulating hormone\u2013gonadotropin-releasing hormone antagonist in vitro fertilization cycles","volume":"100","author":"Fatemi","year":"2013","journal-title":"Fertil Steril"},{"key":"2024030111172049400_dead276-B14","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1093\/humrep\/der092","article-title":"ESHRE consensus on the definition of \u2018poor response\u2019 to ovarian stimulation for in vitro fertilization: the Bologna criteria","volume":"26","author":"Ferraretti","year":"2011","journal-title":"Hum Reprod"},{"key":"2024030111172049400_dead276-B15","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1080\/09513590802404013","article-title":"Triggering with HCG or GnRH agonist in GnRH antagonist treated oocyte donation cycles: a randomised clinical trial","volume":"25","author":"Galindo","year":"2009","journal-title":"Gynecol Endocrinol"},{"key":"2024030111172049400_dead276-B16","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1007\/s10815-020-01966-5","article-title":"How effective are the non-conventional ovarian stimulation protocols in ART? A systematic review and meta-analysis","volume":"37","author":"Glujovsky","year":"2020","journal-title":"J Assist Reprod Genet"},{"key":"2024030111172049400_dead276-B17","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1210\/jcem-71-4-918","article-title":"Use of gonadotropin-releasing hormone agonist to trigger follicular maturation for in vitro fertilization","volume":"71","author":"Gonen","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"2024030111172049400_dead276-B18","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/humupd\/dmi045","article-title":"GnRH agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol: a systematic review and meta-analysis","volume":"12","author":"Griesinger","year":"2006","journal-title":"Hum Reprod Update"},{"key":"2024030111172049400_dead276-B19","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ejogrb.2018.11.002","article-title":"Comparison of the follicular output rate after controlled ovarian stimulation with daily recombinant follicle-stimulating hormone versus corifollitropin alfa","volume":"232","author":"Griesinger","year":"2019","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2024030111172049400_dead276-B20","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1093\/humrep\/deaa107","article-title":"GnRH agonist and hCG (dual trigger) versus hCG trigger for final follicular maturation: a double-blinded, randomized controlled study","volume":"35","author":"Haas","year":"2020","journal-title":"Hum Reprod"},{"key":"2024030111172049400_dead276-B21","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1080\/09513590.2019.1576621","article-title":"Does double trigger (GnRH-agonist + hCG) improve outcome in poor responders undergoing IVF-ET cycle? A pilot study","volume":"35","author":"Haas","year":"2019","journal-title":"Gynecol Endocrinol"},{"key":"2024030111172049400_dead276-B22","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.fertnstert.2008.03.077","article-title":"No room for cancellation, coasting, or ovarian hyperstimulation syndrome in oocyte donation cycles","volume":"91","author":"Hern\u00e1ndez","year":"2009","journal-title":"Fertil Steril"},{"key":"2024030111172049400_dead276-B23","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1093\/humrep\/deh765","article-title":"GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF\/ICSI cycles: a prospective randomized study","volume":"20","author":"Humaidan","year":"2005","journal-title":"Hum Reprod"},{"key":"2024030111172049400_dead276-B24","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.rbmo.2014.08.009","article-title":"Double stimulations during the follicular and luteal phases of poor responders in IVF\/ICSI programmes (Shanghai protocol)","volume":"29","author":"Kuang","year":"2014","journal-title":"Reprod Biomed Online"},{"key":"2024030111172049400_dead276-B25","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.fertnstert.2013.09.007","article-title":"Luteal-phase ovarian stimulation is feasible for producing competent oocytes in women undergoing in vitro fertilization\/intracytoplasmic sperm injection treatment, with optimal pregnancy outcomes in frozen-thawed embryo transfer cycles","volume":"101","author":"Kuang","year":"2014","journal-title":"Fertil Steril"},{"key":"2024030111172049400_dead276-B26","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/humrep\/deq374","article-title":"Outcome of closed blastocyst vitrification in relation to blastocyst quality: evaluation of 759 warming cycles in a single-embryo transfer policy","volume":"26","author":"Landuyt","year":"2011","journal-title":"Hum Reprod"},{"key":"2024030111172049400_dead276-B27","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.fertnstert.2004.10.054","article-title":"Blastocyst formation in in vitro fertilization versus intracytoplasmic sperm injection cycles: influence of the fertilization procedure","volume":"83","author":"Landuyt","year":"2005","journal-title":"Fertil Steril"},{"key":"2024030111172049400_dead276-B28","doi-asserted-by":"crossref","first-page":"e0176600","DOI":"10.1371\/journal.pone.0176600","article-title":"Individual luteolysis pattern after GnRH-agonist trigger for final oocyte maturation","volume":"12","author":"Lawrenz","year":"2017","journal-title":"PLoS One"},{"key":"2024030111172049400_dead276-B29","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/ijgo.13405","article-title":"Comparative study between single versus dual trigger for poor responders in GnRH-antagonist ICSI cycles: A randomized controlled study","volume":"152","author":"Maged","year":"2021","journal-title":"Int J Gynaecol Obstet"},{"key":"2024030111172049400_dead276-B30","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1093\/humrep\/dead038","article-title":"The BISTIM study: a randomized controlled trial comparing dual ovarian stimulation (duostim) with two conventional ovarian stimulations in poor ovarian responders undergoing IVF","volume":"38","author":"Massin","year":"2023","journal-title":"Hum Reprod"},{"key":"2024030111172049400_dead276-B31","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1007\/s10815-015-0541-z","article-title":"Reduced blastocyst formation in reduced culture volume","volume":"32","author":"Munck","year":"2015","journal-title":"J Assist Reprod Genet"},{"key":"2024030111172049400_dead276-B32","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/molehr\/gaw029","article-title":"Transcriptional characteristics of different sized follicles in relation to embryo transferability: potential role of hepatocyte growth factor signalling","volume":"22","author":"Nivet","year":"2016","journal-title":"Mol Hum Reprod"},{"key":"2024030111172049400_dead276-B33","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1093\/humrep\/det045","article-title":"Addition of highly purified HMG after corifollitropin alfa in antagonist-treated poor ovarian responders: a pilot study","volume":"28","author":"Polyzos","year":"2013","journal-title":"Hum Reprod"},{"key":"2024030111172049400_dead276-B34","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1093\/humrep\/deab017","article-title":"DuoStim: are we really comparing follicular phase with luteal phase stimulations?","volume":"36","author":"Racca","year":"2021","journal-title":"Hum Reprod"},{"key":"2024030111172049400_dead276-B35","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.rbmo.2021.08.012","article-title":"Measuring success in IVF is a complex multidisciplinary task: time for a consensus?","volume":"43","author":"Rienzi","year":"2021","journal-title":"Reprod Biomed Online"},{"key":"2024030111172049400_dead276-B36","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s10815-019-01638-z","article-title":"What is the true place of a double stimulation and double oocyte retrieval in the same cycle for patients diagnosed with poor ovarian reserve? A systematic review including a meta-analytical approach","volume":"37","author":"Sfakianoudis","year":"2020","journal-title":"J Assist Reprod Genet"},{"key":"2024030111172049400_dead276-B37","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.fertnstert.2006.11.069","article-title":"Comparison of human chorionic gonadotropin and gonadotropin-releasing hormone agonist for final oocyte maturation in oocyte donor cycles","volume":"88","author":"Shapiro","year":"2007","journal-title":"Fertil Steril"},{"key":"2024030111172049400_dead276-B152","doi-asserted-by":"crossref","first-page":"2125.e9","DOI":"10.1016\/j.fertnstert.2011.01.030","article-title":"Random-start controlled ovarian hyperstimulation for emergency fertility preservation in letrozole cycles","volume":"95","author":"S\u00f6nmezer","year":"2011","journal-title":"Fertil Steril"},{"key":"2024030111172049400_dead276-B38","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1093\/humrep\/der106","article-title":"Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles","volume":"26","author":"Sunkara","year":"2011","journal-title":"Hum Reprod"},{"key":"2024030111172049400_dead276-B39","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/humrep\/dead002","article-title":"Routine double-ovarian-stimulation (DuoStim) in poor responders lacks rationale, evidence, and follow-up","volume":"38","author":"Tocci","year":"2023","journal-title":"Hum Reprod"},{"key":"2024030111172049400_dead276-B40","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/j.fertnstert.2016.03.002","article-title":"Follicular versus luteal phase ovarian stimulation during the same menstrual cycle (DuoStim) in a reduced ovarian reserve population results in a similar euploid blastocyst formation rate: new insight in ovarian reserve exploitation","volume":"105","author":"Ubaldi","year":"2016","journal-title":"Fertil Steril"},{"key":"2024030111172049400_dead276-B41","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.fertnstert.2019.09.012","article-title":"Luteal phase after conventional stimulation in the same ovarian cycle might improve the management of poor responder patients fulfilling the Bologna criteria: a case series","volume":"113","author":"Vaiarelli","year":"2020","journal-title":"Fertil Steril"},{"key":"2024030111172049400_dead276-B42","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s10815-022-02409-z","article-title":"Second stimulation in the same ovarian cycle: an option to fully-personalize the treatment in poor prognosis patients undergoing PGT-A","volume":"39","author":"Vaiarelli","year":"2022","journal-title":"J Assist Reprod Genet"},{"key":"2024030111172049400_dead276-B43","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3389\/fendo.2018.00317","article-title":"Double stimulation in the same ovarian cycle (DuoStim) to maximize the number of oocytes retrieved from poor prognosis patients: a multicenter experience and SWOT analysis","volume":"9","author":"Vaiarelli","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2024030111172049400_dead276-B44","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/GCO.0000000000000452","article-title":"What is new in the management of poor ovarian response in IVF?","volume":"30","author":"Vaiarelli","year":"2018","journal-title":"Curr Opin Obstet Gynecol"},{"key":"2024030111172049400_dead276-B45","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1093\/humrep\/dex234","article-title":"The International Glossary on Infertility and Fertility Care, 2017","volume":"32","author":"Zegers-Hochschild","year":"2017","journal-title":"Hum Reprod"},{"key":"2024030111172049400_dead276-B46","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1093\/humrep\/deac114","article-title":"Ovulation triggering with hCG alone, GnRH agonist alone or in combination? A randomized controlled trial in advanced-age women undergoing IVF\/ICSI cycles","volume":"37","author":"Zhou","year":"2022","journal-title":"Hum Reprod"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/humrep\/article-pdf\/39\/3\/538\/56808316\/dead276.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/humrep\/article-pdf\/39\/3\/538\/56808316\/dead276.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T14:31:57Z","timestamp":1730903517000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humrep\/article\/39\/3\/538\/7515223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,10]]},"references-count":48,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,1,10]]},"published-print":{"date-parts":[[2024,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/dead276","relation":{},"ISSN":["0268-1161","1460-2350"],"issn-type":[{"value":"0268-1161","type":"print"},{"value":"1460-2350","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,3,1]]},"published":{"date-parts":[[2024,1,10]]}}}